[Induction of anaesthesia. Haemodynamic incidence in patients with ischaemic myocardiopathy (author's transl)].
Haemodynamic incidence of induction of anaesthesia was evaluated in four groups of 10 patients in general surgery: patients without heart disease (gr. I), patients with ischaemic myocardiopathy (gr. II, gr. IV), patients with ischaemic heart disease who were digitalized before anaesthesis (gr. III). An anaesthetic technique comprising a combination of phenoperidine, thiopentone, suxamethonium, pancuronium, N2O/O2 was used in groups I, II, III and patients of group IV were anaesthetized with a protocol of narconeuroleptanalgesia (phenoperidine, droperidol, thiopentone, pancuronium, N2O/O2). Induction of anaesthesia in patient with ischaemic myocardiopathy leads to haemodynamic changes with a predominant decrease of mean arterial pressure. But the haemodynamic changes are less important with neuroleptanalgesia than with balanced anaesthesia. With neuroleptanalgesia decrease of mean arterial pressure is rather less important than with balanced anaesthesia and it is not coupled with a significant decrease of cardiac index but only with a decrease of total peripheral resistances. On contrary with balanced anaesthesia decrease of mean arterial pressure is connected with a significant decrease of cardiac index related to a decrease of systolic index. Pre-operative digitalization do not attenuate cardiac and haemodynamic changes occurring after induction and balanced anaesthesia. Though neuroleptanalgesia appears to be a safe technique in patients with ischaemic heart disease.
D000005:Abdomen / Q000601:surgery; D000136:Acid-Base Equilibrium; D000368:Aged; D000768:Anesthesia, General / Q000009:adverse effects*; D003327:Coronary Disease / Q000503:physiopathology*; D004077:Digoxin / Q000097:blood; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D008875:Middle Aged; D009458:Neuroleptanalgesia / Q000009:adverse effects*; D010100:Oxygen / Q000097:blood
D004077:Digoxin; D010100:Oxygen
Effets hémodynamiques de l'induction anesthésique chez le patient porteur d'une cardiopathie ischémique.